Glycerin Derived Tears Segment has the Largest Share of Type in the North America Artificial Tears Market during 2021-2028.
According to a new market research study on “North America Artificial Tears Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type, Delivery Mode, and Application,” is expected to reach US$ 2,392.8 million by 2028 from US$ 1,672.6 million in 2021. The market is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The report provides trends prevailing in the North America Artificial tears market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidence of dry eye and the growing older population are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor accessibility to eye care services in countries.
Several measures are being taken to treat the disease and prevent transmission; however, the exorbitant number of COVID- 19 cases has resulted in the cancellation of the doctor's appointment. With COVID-19 continuing to spread all over the world, researchers are looking into numerous options for possible treatment, including existing options. In July 2020, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the findings of a new survey, coincide with Dry Eye Awareness Month. The survey of 1,005 nationally representative U.S. adults, conducted by research firm Ipsos, reveals the influence of the COVID-19 pandemic on consumers' screen time and how it affects their perceptions of eye health. According to the survey Nearly 80% of Americans reported their screen time increased during the COVID-19 pandemic. Three out of five (60%) people who have increased their screen time are concerned about the impact on their eyes. Nearly half (45%) of individuals who spend more time in front of the screen say it makes their eyes dry. These factors had a potential impact on the North America artificial tears market.
The market for Artificial tears market is segmented into type, delivery mode, and application. Based on type, the artificial tears market is segmented into glycerin derived tears, cellulose derived tears, oil-based emulsion tears, polythylene glycol-based tears, sodium hyaluronate based artificial tears, and propylene glycol-based tears. In 2020, glycerin derived tears segment accounted for the largest share of the market owing to their easy availability and ability to keep eyes moist for long. Glycerin is a humectant, as well as a demulcent and lubricant. Glycerin also has the benefit of promoting epithelial cell growth and reducing the harmful effects of high osmolarity on the ocular surface. Povidone is a lipid that binds to the tear film's existing oil layer, thickening it and reducing evaporation.
Johnson and Johnson Services, Inc. Alcon Inc. OASIS Medical, AbbVie Inc. Bayer AG, Prestige Consumer Healthcare Inc. Santen Pharmaceutical Co. Ltd. Bausch Health Companies Inc. and Akorn, Incorporated are among the leading companies in the North America Artificial tears market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, Bausch + Lomb launched Alaway® Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops, the first and only over the counter (OTC) preservative-free antihistamine eye itch relief drop approved by the U.S. Food and Drug Administration.
According to a new market research study on “North America Artificial Tears Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type, Delivery Mode, and Application,” is expected to reach US$ 2,392.8 million by 2028 from US$ 1,672.6 million in 2021. The market is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The report provides trends prevailing in the North America Artificial tears market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising incidence of dry eye and the growing older population are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the poor accessibility to eye care services in countries.
Several measures are being taken to treat the disease and prevent transmission; however, the exorbitant number of COVID- 19 cases has resulted in the cancellation of the doctor's appointment. With COVID-19 continuing to spread all over the world, researchers are looking into numerous options for possible treatment, including existing options. In July 2020, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the findings of a new survey, coincide with Dry Eye Awareness Month. The survey of 1,005 nationally representative U.S. adults, conducted by research firm Ipsos, reveals the influence of the COVID-19 pandemic on consumers' screen time and how it affects their perceptions of eye health. According to the survey Nearly 80% of Americans reported their screen time increased during the COVID-19 pandemic. Three out of five (60%) people who have increased their screen time are concerned about the impact on their eyes. Nearly half (45%) of individuals who spend more time in front of the screen say it makes their eyes dry. These factors had a potential impact on the North America artificial tears market.
The market for Artificial tears market is segmented into type, delivery mode, and application. Based on type, the artificial tears market is segmented into glycerin derived tears, cellulose derived tears, oil-based emulsion tears, polythylene glycol-based tears, sodium hyaluronate based artificial tears, and propylene glycol-based tears. In 2020, glycerin derived tears segment accounted for the largest share of the market owing to their easy availability and ability to keep eyes moist for long. Glycerin is a humectant, as well as a demulcent and lubricant. Glycerin also has the benefit of promoting epithelial cell growth and reducing the harmful effects of high osmolarity on the ocular surface. Povidone is a lipid that binds to the tear film's existing oil layer, thickening it and reducing evaporation.
Johnson and Johnson Services, Inc. Alcon Inc. OASIS Medical, AbbVie Inc. Bayer AG, Prestige Consumer Healthcare Inc. Santen Pharmaceutical Co. Ltd. Bausch Health Companies Inc. and Akorn, Incorporated are among the leading companies in the North America Artificial tears market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, Bausch + Lomb launched Alaway® Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops, the first and only over the counter (OTC) preservative-free antihistamine eye itch relief drop approved by the U.S. Food and Drug Administration.
The report segments the North America Artificial Tears market as follows:
By Type
- Glycerin Derived Tears
- Cellulose Derived Tears
- Oil-based Emulsion Tears
- Polythylene Glycol Based Tears
- Sodium Hyaluronate Based Artificial Tears
- Propylene Glycol Based Tears
By Delivery Mode
- Eye Drops
- Ointments
By Application
- Dry Eyes Treatment
- Contact Lenses Moisture
By Country
- North America
- US
- Canada
- Mexico
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America artificial tears market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America artificial tears market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the artificial tears market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. North America Artificial Tears Market - Market Landscape
5. North America Artificial Tears Market - Key Market Dynamics
6. Artificial Tears Market - North America Analysis
7. North America Artificial Tears Market Analysis and Forecasts To 2028 - By Type
8. North America Artificial Tears Market Analysis and Forecasts To 2028 - By Delivery Mode
9. North America Artificial Tears Market Analysis and Forecasts to 2028 - By Application
10. Artificial Tears Market Revenue and Forecasts to 2028 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on North America Artificial Tears Market
12. Industry Landscape
13. COMPANY PROFILES
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson and Johnson Services, Inc.
- Alcon Inc.
- OASIS Medical
- AbbVie Inc.
- Bayer AG
- Prestige Consumer Healthcare Inc.
- Santen Pharmaceutical Co., Ltd.
- Bausch Health Companies Inc.
- Akorn, Incorporated
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 122 |
Published | July 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 1672.6 Million |
Forecasted Market Value ( USD | $ 2392.8 Million |
Compound Annual Growth Rate | 5.2% |
Regions Covered | North America |